These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14865894)

  • 1. [Action of 4-amino pteroyl glutamic acid (aminopterin) in vitro on a culture of bone marrow of pernicious anemia].
    FRANCO J; ARKUN SN
    Sang; 1951; 22(5):413-25. PubMed ID: 14865894
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of pernicious anemia with pteroyl glutamic acid (folic acid).
    SCHWARTZ SO; ARMSTRONG BE
    Proc Annu Meet Cent Soc Clin Res U S; 1947; 20():36. PubMed ID: 20272798
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined system disease and hematologic relapse occurring in persons with pernicious anemia treated with synthetic folic acid (pteroyl glutamic acid) for a period of two years.
    VILTER RW; VILTER CF; HAWKINS V
    Proc Annu Meet Cent Soc Clin Res U S; 1947; 20():35. PubMed ID: 20272797
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth inhibition in amphibian larvae by 4-amino pteroyl-glutamic acid (aminopterin).
    ROSENBAUM RM; VELARDO JT
    Nature; 1951 Sep; 168(4271):424-5. PubMed ID: 14875112
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction of Excess Acetylcholine in the Serum of Pernicious Anemia Patients by Treatment With Pteroyl Glutamic Acid, Liver Extract, or Ventriculin.
    Davis JE
    Science; 1946 Dec; 104(2712):605-6. PubMed ID: 17749270
    [No Abstract]   [Full Text] [Related]  

  • 6. Aminopterin (4-amino-pteroyl-glutamic acid) therapy in leukemias.
    HUNTER OB; CARROLL GJ
    Ann West Med Surg; 1949 Nov; 3(11):380-4. PubMed ID: 15394615
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on the utilization of pteroyl hexaglutamyl glutamic acid (vitamin Bc conjugate) in pernicious anemia.
    BETHELL FH; SWENDSEID ME
    Proc Annu Meet Cent Soc Clin Res U S; 1946 Nov 1-2; 19():28. PubMed ID: 20248533
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of pernicious anemia with pteroyl-triglutamic acid (teropterin).
    MEYER LM; RITZ ND; FINK H; MILBERG MS
    Acta Med Scand; 1951; 140(4):307-16. PubMed ID: 14877511
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on the utilization of pteroyl hexaglutamyl glutamic acid (vitamin Bc conjugate) in pernicious anemia.
    BETHELL FH; SWENDSEID ME
    J Lab Clin Med; 1947 Mar; 32(3):337-40. PubMed ID: 20289823
    [No Abstract]   [Full Text] [Related]  

  • 10. The cytology of the erythrogenic reticulum of the bone marrow in pernicious anemia before and after administering folic acid.
    FAHR G; WALCH AE
    Minn Med; 1946 Dec; 29(12):1212-4. PubMed ID: 20278778
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies in pernicious anemia patients treated with liver extract and folic acid antagonists.
    MEYER LM; RITZ ND
    Am J Med Sci; 1949 Aug; 218(2):197-203. PubMed ID: 18147209
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemopoietic response to folic acid in pernicious anaemia; the sternal-marrow changes.
    HARRISON RJ; WHITE JC
    Lancet; 1946 Nov; 2(6431):787-91. PubMed ID: 20276562
    [No Abstract]   [Full Text] [Related]  

  • 13. [CASE OF PERNICIOUS ANEMIA IN CHILDHOOD].
    NIHO Y; OTAKE N; HATTORI K
    Naika; 1964 Feb; 13():377-82. PubMed ID: 14141151
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of folic acid and aminopterin upon enzyme systems in vitro.
    WILLIAMS JN
    J Biol Chem; 1950 Nov; 187(1):47-54. PubMed ID: 14794688
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of acute leukemia with amethopterin (4-amino, 10-methyl pteroyl glutamic acid).
    MEYER LM; MILLER FR; ROWEN MJ; BOCK G; RUTZKY J
    Acta Haematol; 1950 Sep; 4(3):157-67. PubMed ID: 14777272
    [No Abstract]   [Full Text] [Related]  

  • 16. [A little known modification of the intestinal villi in 4-amino-pteroyl-glutamic acid poisoning in the guinea pig].
    BASERGA A; MARINONE G
    Farmaco Sci Tec; 1951; 6(2):196-9. PubMed ID: 14849599
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the biochemical defect of pernicious anemia. I. In vitro observations on oxygen consumption, heme synthesis and deoxyribonucleic acid synthesis by pernicious anemia bone marrow.
    THOMAS ED; LOCHTE HL
    J Clin Invest; 1958 Feb; 37(2):166-71. PubMed ID: 13513747
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations on response of macrocytic anemias to folic acid therapy with special reference to the type of erythropoiesis present as revealed by bone marrow aspiration.
    BERMAN L; JACOBSON SD; VONDER HEIDE EC
    Proc Annu Meet Cent Soc Clin Res U S; 1946 Nov 1-2; 19():55. PubMed ID: 20343582
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenesis of megaloblastosis in pernicious anemia determined by the in vitro culture of the bone marrow].
    LATTANZI A; SICCA GT
    Rass Fisiopatol Clin Ter; 1952 Nov; 24(11):1393-1411. PubMed ID: 13100681
    [No Abstract]   [Full Text] [Related]  

  • 20. The hematologic changes induced in guinea pigs by the prolonged administration of pteroyl glutamic acid antagonists.
    INNES J; INNES EM; MOORE CV
    J Lab Clin Med; 1949 Jul; 34(7):883-901. PubMed ID: 18133819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.